nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—CYP2C19—Dapsone—systemic lupus erythematosus	0.0628	0.135	CbGbCtD
Atomoxetine—CYP2C19—Prednisone—systemic lupus erythematosus	0.0435	0.0937	CbGbCtD
Atomoxetine—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0413	0.0888	CbGbCtD
Atomoxetine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0347	0.0748	CbGbCtD
Atomoxetine—HTR2C—choroid plexus—systemic lupus erythematosus	0.0322	0.235	CbGeAlD
Atomoxetine—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0314	0.0675	CbGbCtD
Atomoxetine—CYP3A4—Dapsone—systemic lupus erythematosus	0.0304	0.0653	CbGbCtD
Atomoxetine—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0272	0.0585	CbGbCtD
Atomoxetine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0263	0.0567	CbGbCtD
Atomoxetine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0263	0.0567	CbGbCtD
Atomoxetine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0226	0.0486	CbGbCtD
Atomoxetine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0223	0.048	CbGbCtD
Atomoxetine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0211	0.0455	CbGbCtD
Atomoxetine—CYP3A4—Prednisone—systemic lupus erythematosus	0.0211	0.0453	CbGbCtD
Atomoxetine—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0207	0.0445	CbGbCtD
Atomoxetine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.02	0.0429	CbGbCtD
Atomoxetine—HTR2A—choroid plexus—systemic lupus erythematosus	0.0161	0.118	CbGeAlD
Atomoxetine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0131	0.0283	CbGbCtD
Atomoxetine—CYP2C19—urine—systemic lupus erythematosus	0.00676	0.0494	CbGeAlD
Atomoxetine—NPY1R—cortex of kidney—systemic lupus erythematosus	0.00488	0.0357	CbGeAlD
Atomoxetine—HTR2A—urine—systemic lupus erythematosus	0.00432	0.0316	CbGeAlD
Atomoxetine—SLC6A4—blood plasma—systemic lupus erythematosus	0.00426	0.0311	CbGeAlD
Atomoxetine—CYP3A4—urine—systemic lupus erythematosus	0.004	0.0292	CbGeAlD
Atomoxetine—CYP2D6—urine—systemic lupus erythematosus	0.00394	0.0288	CbGeAlD
Atomoxetine—NPY1R—lung—systemic lupus erythematosus	0.00355	0.0259	CbGeAlD
Atomoxetine—CYP2C19—blood plasma—systemic lupus erythematosus	0.00353	0.0258	CbGeAlD
Atomoxetine—NPY1R—nervous system—systemic lupus erythematosus	0.00329	0.024	CbGeAlD
Atomoxetine—NPY1R—central nervous system—systemic lupus erythematosus	0.00316	0.0231	CbGeAlD
Atomoxetine—HTR2A—endothelium—systemic lupus erythematosus	0.00254	0.0186	CbGeAlD
Atomoxetine—HTR1D—connective tissue—systemic lupus erythematosus	0.00242	0.0177	CbGeAlD
Atomoxetine—HTR6—nervous system—systemic lupus erythematosus	0.00231	0.0169	CbGeAlD
Atomoxetine—HTR2A—blood plasma—systemic lupus erythematosus	0.00225	0.0165	CbGeAlD
Atomoxetine—HTR6—central nervous system—systemic lupus erythematosus	0.00223	0.0163	CbGeAlD
Atomoxetine—Pseudoephedrine—IL2—systemic lupus erythematosus	0.00219	0.388	CrCbGaD
Atomoxetine—CYP3A4—blood plasma—systemic lupus erythematosus	0.00209	0.0153	CbGeAlD
Atomoxetine—HTR1D—kidney—systemic lupus erythematosus	0.00206	0.015	CbGeAlD
Atomoxetine—CYP2D6—blood plasma—systemic lupus erythematosus	0.00205	0.015	CbGeAlD
Atomoxetine—SLC6A3—lung—systemic lupus erythematosus	0.00149	0.0109	CbGeAlD
Atomoxetine—HTR1B—nervous system—systemic lupus erythematosus	0.00139	0.0102	CbGeAlD
Atomoxetine—SLC6A3—nervous system—systemic lupus erythematosus	0.00138	0.0101	CbGeAlD
Atomoxetine—SLC6A4—lung—systemic lupus erythematosus	0.00137	0.01	CbGeAlD
Atomoxetine—HTR1D—nervous system—systemic lupus erythematosus	0.00135	0.00987	CbGeAlD
Atomoxetine—HTR1B—central nervous system—systemic lupus erythematosus	0.00134	0.00981	CbGeAlD
Atomoxetine—HTR2C—nervous system—systemic lupus erythematosus	0.00134	0.00977	CbGeAlD
Atomoxetine—SLC6A3—central nervous system—systemic lupus erythematosus	0.00133	0.00973	CbGeAlD
Atomoxetine—HTR1D—central nervous system—systemic lupus erythematosus	0.0013	0.0095	CbGeAlD
Atomoxetine—HTR2C—central nervous system—systemic lupus erythematosus	0.00129	0.00941	CbGeAlD
Atomoxetine—SLC6A4—nervous system—systemic lupus erythematosus	0.00127	0.00926	CbGeAlD
Atomoxetine—SLC6A4—central nervous system—systemic lupus erythematosus	0.00122	0.00892	CbGeAlD
Atomoxetine—SLC6A2—lung—systemic lupus erythematosus	0.0012	0.0088	CbGeAlD
Atomoxetine—HTR2A—connective tissue—systemic lupus erythematosus	0.0012	0.00877	CbGeAlD
Atomoxetine—SLC6A2—nervous system—systemic lupus erythematosus	0.00112	0.00815	CbGeAlD
Atomoxetine—SLC6A2—central nervous system—systemic lupus erythematosus	0.00107	0.00785	CbGeAlD
Atomoxetine—HTR2A—kidney—systemic lupus erythematosus	0.00102	0.00747	CbGeAlD
Atomoxetine—CYP3A4—kidney—systemic lupus erythematosus	0.000946	0.00691	CbGeAlD
Atomoxetine—CYP2D6—kidney—systemic lupus erythematosus	0.000931	0.0068	CbGeAlD
Atomoxetine—HTR2A—tendon—systemic lupus erythematosus	0.000825	0.00603	CbGeAlD
Atomoxetine—Pseudoephedrine—TNF—systemic lupus erythematosus	0.00074	0.131	CrCbGaD
Atomoxetine—HTR2A—lung—systemic lupus erythematosus	0.000724	0.00529	CbGeAlD
Atomoxetine—HTR2A—nervous system—systemic lupus erythematosus	0.00067	0.0049	CbGeAlD
Atomoxetine—HTR2A—central nervous system—systemic lupus erythematosus	0.000645	0.00472	CbGeAlD
Atomoxetine—CYP3A4—nervous system—systemic lupus erythematosus	0.000621	0.00454	CbGeAlD
Atomoxetine—CYP2D6—nervous system—systemic lupus erythematosus	0.000611	0.00446	CbGeAlD
Atomoxetine—CYP3A4—central nervous system—systemic lupus erythematosus	0.000598	0.00437	CbGeAlD
Atomoxetine—CYP2D6—central nervous system—systemic lupus erythematosus	0.000588	0.0043	CbGeAlD
Atomoxetine—Fenoprofen—PTGS2—systemic lupus erythematosus	0.000482	0.0855	CrCbGaD
Atomoxetine—Fenoprofen—ALB—systemic lupus erythematosus	0.00043	0.0761	CrCbGaD
Atomoxetine—Phenprocoumon—ALB—systemic lupus erythematosus	0.00037	0.0657	CrCbGaD
Atomoxetine—Fluoxetine—ALB—systemic lupus erythematosus	0.00036	0.0639	CrCbGaD
Atomoxetine—Warfarin—ALB—systemic lupus erythematosus	0.000329	0.0582	CrCbGaD
Atomoxetine—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000302	0.000796	CcSEcCtD
Atomoxetine—Rash—Leflunomide—systemic lupus erythematosus	0.000302	0.000796	CcSEcCtD
Atomoxetine—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000301	0.000796	CcSEcCtD
Atomoxetine—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000301	0.000795	CcSEcCtD
Atomoxetine—Mental disorder—Prednisone—systemic lupus erythematosus	0.000301	0.000795	CcSEcCtD
Atomoxetine—Nausea—Azathioprine—systemic lupus erythematosus	0.000301	0.000794	CcSEcCtD
Atomoxetine—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000301	0.000794	CcSEcCtD
Atomoxetine—Headache—Leflunomide—systemic lupus erythematosus	0.0003	0.000791	CcSEcCtD
Atomoxetine—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000299	0.00079	CcSEcCtD
Atomoxetine—Malnutrition—Prednisone—systemic lupus erythematosus	0.000299	0.00079	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000299	0.000789	CcSEcCtD
Atomoxetine—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000299	0.000788	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000298	0.000787	CcSEcCtD
Atomoxetine—Convulsion—Betamethasone—systemic lupus erythematosus	0.000297	0.000786	CcSEcCtD
Atomoxetine—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000297	0.000786	CcSEcCtD
Atomoxetine—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000297	0.000783	CcSEcCtD
Atomoxetine—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000297	0.000783	CcSEcCtD
Atomoxetine—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000295	0.000778	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000294	0.000777	CcSEcCtD
Atomoxetine—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000293	0.000774	CcSEcCtD
Atomoxetine—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000292	0.000772	CcSEcCtD
Atomoxetine—Myalgia—Betamethasone—systemic lupus erythematosus	0.000292	0.000772	CcSEcCtD
Atomoxetine—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000292	0.00077	CcSEcCtD
Atomoxetine—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000292	0.00077	CcSEcCtD
Atomoxetine—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000291	0.000769	CcSEcCtD
Atomoxetine—Anxiety—Betamethasone—systemic lupus erythematosus	0.000291	0.000769	CcSEcCtD
Atomoxetine—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000289	0.000762	CcSEcCtD
Atomoxetine—Pain—Prednisolone—systemic lupus erythematosus	0.000287	0.000758	CcSEcCtD
Atomoxetine—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000286	0.000755	CcSEcCtD
Atomoxetine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000285	0.000753	CcSEcCtD
Atomoxetine—Ketoprofen—PTGS2—systemic lupus erythematosus	0.000285	0.0504	CrCbGaD
Atomoxetine—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000285	0.000752	CcSEcCtD
Atomoxetine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000285	0.000752	CcSEcCtD
Atomoxetine—Nausea—Leflunomide—systemic lupus erythematosus	0.000284	0.00075	CcSEcCtD
Atomoxetine—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000283	0.000749	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000283	0.000748	CcSEcCtD
Atomoxetine—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000283	0.000747	CcSEcCtD
Atomoxetine—Vision blurred—Prednisone—systemic lupus erythematosus	0.000282	0.000744	CcSEcCtD
Atomoxetine—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000281	0.000743	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000281	0.000743	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000281	0.000741	CcSEcCtD
Atomoxetine—Pain—Hydrocortisone—systemic lupus erythematosus	0.00028	0.000741	CcSEcCtD
Atomoxetine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000279	0.000738	CcSEcCtD
Atomoxetine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000279	0.000736	CcSEcCtD
Atomoxetine—Infection—Betamethasone—systemic lupus erythematosus	0.000278	0.000735	CcSEcCtD
Atomoxetine—Infection—Dexamethasone—systemic lupus erythematosus	0.000278	0.000735	CcSEcCtD
Atomoxetine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000277	0.000732	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000277	0.000731	CcSEcCtD
Atomoxetine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000277	0.000731	CcSEcCtD
Atomoxetine—Shock—Dexamethasone—systemic lupus erythematosus	0.000276	0.000728	CcSEcCtD
Atomoxetine—Shock—Betamethasone—systemic lupus erythematosus	0.000276	0.000728	CcSEcCtD
Atomoxetine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000275	0.000726	CcSEcCtD
Atomoxetine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000275	0.000726	CcSEcCtD
Atomoxetine—Agitation—Prednisone—systemic lupus erythematosus	0.000275	0.000726	CcSEcCtD
Atomoxetine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000273	0.000722	CcSEcCtD
Atomoxetine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000273	0.000722	CcSEcCtD
Atomoxetine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000272	0.000718	CcSEcCtD
Atomoxetine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000271	0.000716	CcSEcCtD
Atomoxetine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000271	0.000715	CcSEcCtD
Atomoxetine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000271	0.000715	CcSEcCtD
Atomoxetine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.00027	0.000714	CcSEcCtD
Atomoxetine—Vertigo—Prednisone—systemic lupus erythematosus	0.000269	0.000709	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000268	0.000708	CcSEcCtD
Atomoxetine—Syncope—Prednisone—systemic lupus erythematosus	0.000268	0.000708	CcSEcCtD
Atomoxetine—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000267	0.000705	CcSEcCtD
Atomoxetine—Anorexia—Betamethasone—systemic lupus erythematosus	0.000267	0.000705	CcSEcCtD
Atomoxetine—Urticaria—Prednisolone—systemic lupus erythematosus	0.000267	0.000705	CcSEcCtD
Atomoxetine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000266	0.000704	CcSEcCtD
Atomoxetine—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000266	0.000703	CcSEcCtD
Atomoxetine—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000266	0.000702	CcSEcCtD
Atomoxetine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000265	0.000699	CcSEcCtD
Atomoxetine—Pain—Triamcinolone—systemic lupus erythematosus	0.000264	0.000697	CcSEcCtD
Atomoxetine—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000263	0.000694	CcSEcCtD
Atomoxetine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000261	0.00069	CcSEcCtD
Atomoxetine—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000261	0.000688	CcSEcCtD
Atomoxetine—Angiopathy—Methotrexate—systemic lupus erythematosus	0.00026	0.000688	CcSEcCtD
Atomoxetine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000259	0.000685	CcSEcCtD
Atomoxetine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000259	0.000685	CcSEcCtD
Atomoxetine—Convulsion—Prednisone—systemic lupus erythematosus	0.000259	0.000684	CcSEcCtD
Atomoxetine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000259	0.000683	CcSEcCtD
Atomoxetine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000258	0.000682	CcSEcCtD
Atomoxetine—Chills—Methotrexate—systemic lupus erythematosus	0.000258	0.00068	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000255	0.000674	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000255	0.000674	CcSEcCtD
Atomoxetine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000255	0.000673	CcSEcCtD
Atomoxetine—Arthralgia—Prednisone—systemic lupus erythematosus	0.000255	0.000672	CcSEcCtD
Atomoxetine—Myalgia—Prednisone—systemic lupus erythematosus	0.000255	0.000672	CcSEcCtD
Atomoxetine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000254	0.000672	CcSEcCtD
Atomoxetine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000254	0.000671	CcSEcCtD
Atomoxetine—Anxiety—Prednisone—systemic lupus erythematosus	0.000254	0.00067	CcSEcCtD
Atomoxetine—Ketoprofen—ALB—systemic lupus erythematosus	0.000254	0.0449	CrCbGaD
Atomoxetine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000253	0.000669	CcSEcCtD
Atomoxetine—Insomnia—Betamethasone—systemic lupus erythematosus	0.000253	0.000669	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000253	0.000668	CcSEcCtD
Atomoxetine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000253	0.000667	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000252	0.000665	CcSEcCtD
Atomoxetine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000252	0.000664	CcSEcCtD
Atomoxetine—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000252	0.000664	CcSEcCtD
Atomoxetine—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000251	0.000664	CcSEcCtD
Atomoxetine—Malnutrition—Methotrexate—systemic lupus erythematosus	0.00025	0.00066	CcSEcCtD
Atomoxetine—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000247	0.000651	CcSEcCtD
Atomoxetine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000247	0.000651	CcSEcCtD
Atomoxetine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000246	0.00065	CcSEcCtD
Atomoxetine—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000245	0.000648	CcSEcCtD
Atomoxetine—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000245	0.000646	CcSEcCtD
Atomoxetine—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000245	0.000646	CcSEcCtD
Atomoxetine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000244	0.000645	CcSEcCtD
Atomoxetine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000244	0.000644	CcSEcCtD
Atomoxetine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000244	0.000643	CcSEcCtD
Atomoxetine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000244	0.000643	CcSEcCtD
Atomoxetine—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000244	0.000643	CcSEcCtD
Atomoxetine—Infection—Prednisone—systemic lupus erythematosus	0.000242	0.00064	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000242	0.000639	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000242	0.000639	CcSEcCtD
Atomoxetine—Back pain—Methotrexate—systemic lupus erythematosus	0.000242	0.000638	CcSEcCtD
Atomoxetine—Fatigue—Betamethasone—systemic lupus erythematosus	0.000242	0.000638	CcSEcCtD
Atomoxetine—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000242	0.000638	CcSEcCtD
Atomoxetine—Shock—Prednisone—systemic lupus erythematosus	0.00024	0.000634	CcSEcCtD
Atomoxetine—Pain—Dexamethasone—systemic lupus erythematosus	0.00024	0.000633	CcSEcCtD
Atomoxetine—Pain—Betamethasone—systemic lupus erythematosus	0.00024	0.000633	CcSEcCtD
Atomoxetine—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000239	0.000632	CcSEcCtD
Atomoxetine—Tachycardia—Prednisone—systemic lupus erythematosus	0.000238	0.000629	CcSEcCtD
Atomoxetine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000238	0.000629	CcSEcCtD
Atomoxetine—Skin disorder—Prednisone—systemic lupus erythematosus	0.000237	0.000626	CcSEcCtD
Atomoxetine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000236	0.000623	CcSEcCtD
Atomoxetine—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000236	0.000622	CcSEcCtD
Atomoxetine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000235	0.000621	CcSEcCtD
Atomoxetine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000235	0.00062	CcSEcCtD
Atomoxetine—Rash—Cyclosporine—systemic lupus erythematosus	0.000233	0.000615	CcSEcCtD
Atomoxetine—Anorexia—Prednisone—systemic lupus erythematosus	0.000233	0.000614	CcSEcCtD
Atomoxetine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000232	0.000614	CcSEcCtD
Atomoxetine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000232	0.000613	CcSEcCtD
Atomoxetine—Headache—Cyclosporine—systemic lupus erythematosus	0.000231	0.000611	CcSEcCtD
Atomoxetine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000231	0.00061	CcSEcCtD
Atomoxetine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000231	0.00061	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000229	0.000605	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000229	0.000605	CcSEcCtD
Atomoxetine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000229	0.000604	CcSEcCtD
Atomoxetine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000227	0.000599	CcSEcCtD
Atomoxetine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000227	0.000599	CcSEcCtD
Atomoxetine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000226	0.000596	CcSEcCtD
Atomoxetine—Vertigo—Methotrexate—systemic lupus erythematosus	0.000225	0.000593	CcSEcCtD
Atomoxetine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000224	0.000593	CcSEcCtD
Atomoxetine—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000223	0.000588	CcSEcCtD
Atomoxetine—Urticaria—Betamethasone—systemic lupus erythematosus	0.000223	0.000588	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000222	0.000587	CcSEcCtD
Atomoxetine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000222	0.000586	CcSEcCtD
Atomoxetine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000222	0.000585	CcSEcCtD
Atomoxetine—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000222	0.000585	CcSEcCtD
Atomoxetine—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000222	0.000585	CcSEcCtD
Atomoxetine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000222	0.000585	CcSEcCtD
Atomoxetine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000222	0.000585	CcSEcCtD
Atomoxetine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000221	0.000584	CcSEcCtD
Atomoxetine—Insomnia—Prednisone—systemic lupus erythematosus	0.000221	0.000583	CcSEcCtD
Atomoxetine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000219	0.000579	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000219	0.000579	CcSEcCtD
Atomoxetine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000218	0.000577	CcSEcCtD
Atomoxetine—Cough—Methotrexate—systemic lupus erythematosus	0.000218	0.000576	CcSEcCtD
Atomoxetine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000218	0.000576	CcSEcCtD
Atomoxetine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000217	0.000573	CcSEcCtD
Atomoxetine—Convulsion—Methotrexate—systemic lupus erythematosus	0.000217	0.000572	CcSEcCtD
Atomoxetine—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000215	0.000567	CcSEcCtD
Atomoxetine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000214	0.000565	CcSEcCtD
Atomoxetine—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000213	0.000562	CcSEcCtD
Atomoxetine—Myalgia—Methotrexate—systemic lupus erythematosus	0.000213	0.000562	CcSEcCtD
Atomoxetine—Chest pain—Methotrexate—systemic lupus erythematosus	0.000213	0.000562	CcSEcCtD
Atomoxetine—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000212	0.00056	CcSEcCtD
Atomoxetine—Rash—Prednisolone—systemic lupus erythematosus	0.000212	0.000559	CcSEcCtD
Atomoxetine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000212	0.000559	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000211	0.000558	CcSEcCtD
Atomoxetine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000211	0.000557	CcSEcCtD
Atomoxetine—Fatigue—Prednisone—systemic lupus erythematosus	0.00021	0.000556	CcSEcCtD
Atomoxetine—Headache—Prednisolone—systemic lupus erythematosus	0.00021	0.000556	CcSEcCtD
Atomoxetine—Constipation—Prednisone—systemic lupus erythematosus	0.000209	0.000551	CcSEcCtD
Atomoxetine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000209	0.000551	CcSEcCtD
Atomoxetine—Rash—Hydrocortisone—systemic lupus erythematosus	0.000207	0.000546	CcSEcCtD
Atomoxetine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000207	0.000546	CcSEcCtD
Atomoxetine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000205	0.000543	CcSEcCtD
Atomoxetine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000204	0.000539	CcSEcCtD
Atomoxetine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000204	0.000538	CcSEcCtD
Atomoxetine—Infection—Methotrexate—systemic lupus erythematosus	0.000203	0.000535	CcSEcCtD
Atomoxetine—Nortriptyline—ALB—systemic lupus erythematosus	0.000202	0.0358	CrCbGaD
Atomoxetine—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000201	0.000531	CcSEcCtD
Atomoxetine—Asthenia—Betamethasone—systemic lupus erythematosus	0.000201	0.000531	CcSEcCtD
Atomoxetine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000201	0.000531	CcSEcCtD
Atomoxetine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.0002	0.000528	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.0002	0.000527	CcSEcCtD
Atomoxetine—Nausea—Prednisolone—systemic lupus erythematosus	0.000199	0.000527	CcSEcCtD
Atomoxetine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000198	0.000524	CcSEcCtD
Atomoxetine—Pruritus—Betamethasone—systemic lupus erythematosus	0.000198	0.000524	CcSEcCtD
Atomoxetine—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000198	0.000523	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000197	0.000521	CcSEcCtD
Atomoxetine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000196	0.000519	CcSEcCtD
Atomoxetine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000196	0.000517	CcSEcCtD
Atomoxetine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000195	0.000514	CcSEcCtD
Atomoxetine—Rash—Triamcinolone—systemic lupus erythematosus	0.000195	0.000514	CcSEcCtD
Atomoxetine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000195	0.000514	CcSEcCtD
Atomoxetine—Anorexia—Methotrexate—systemic lupus erythematosus	0.000194	0.000513	CcSEcCtD
Atomoxetine—Rash—Methylprednisolone—systemic lupus erythematosus	0.000194	0.000513	CcSEcCtD
Atomoxetine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000194	0.000513	CcSEcCtD
Atomoxetine—Urticaria—Prednisone—systemic lupus erythematosus	0.000194	0.000512	CcSEcCtD
Atomoxetine—Headache—Triamcinolone—systemic lupus erythematosus	0.000193	0.000511	CcSEcCtD
Atomoxetine—Headache—Methylprednisolone—systemic lupus erythematosus	0.000193	0.00051	CcSEcCtD
Atomoxetine—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000193	0.000509	CcSEcCtD
Atomoxetine—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000193	0.000509	CcSEcCtD
Atomoxetine—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000192	0.000506	CcSEcCtD
Atomoxetine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000192	0.000506	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000186	0.000491	CcSEcCtD
Atomoxetine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000185	0.000489	CcSEcCtD
Atomoxetine—Dizziness—Betamethasone—systemic lupus erythematosus	0.000185	0.000489	CcSEcCtD
Atomoxetine—Insomnia—Methotrexate—systemic lupus erythematosus	0.000184	0.000487	CcSEcCtD
Atomoxetine—Nausea—Triamcinolone—systemic lupus erythematosus	0.000183	0.000484	CcSEcCtD
Atomoxetine—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000183	0.000484	CcSEcCtD
Atomoxetine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000183	0.000483	CcSEcCtD
Atomoxetine—Somnolence—Methotrexate—systemic lupus erythematosus	0.000181	0.000479	CcSEcCtD
Atomoxetine—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.00018	0.000474	CcSEcCtD
Atomoxetine—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000178	0.000471	CcSEcCtD
Atomoxetine—Vomiting—Betamethasone—systemic lupus erythematosus	0.000178	0.000471	CcSEcCtD
Atomoxetine—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000177	0.000468	CcSEcCtD
Atomoxetine—Rash—Dexamethasone—systemic lupus erythematosus	0.000177	0.000467	CcSEcCtD
Atomoxetine—Rash—Betamethasone—systemic lupus erythematosus	0.000177	0.000467	CcSEcCtD
Atomoxetine—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000177	0.000466	CcSEcCtD
Atomoxetine—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000177	0.000466	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000176	0.000465	CcSEcCtD
Atomoxetine—Fatigue—Methotrexate—systemic lupus erythematosus	0.000176	0.000464	CcSEcCtD
Atomoxetine—Headache—Dexamethasone—systemic lupus erythematosus	0.000176	0.000464	CcSEcCtD
Atomoxetine—Headache—Betamethasone—systemic lupus erythematosus	0.000176	0.000464	CcSEcCtD
Atomoxetine—Asthenia—Prednisone—systemic lupus erythematosus	0.000175	0.000462	CcSEcCtD
Atomoxetine—Pain—Methotrexate—systemic lupus erythematosus	0.000174	0.000461	CcSEcCtD
Atomoxetine—Pruritus—Prednisone—systemic lupus erythematosus	0.000173	0.000456	CcSEcCtD
Atomoxetine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000168	0.000444	CcSEcCtD
Atomoxetine—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000167	0.000441	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000167	0.00044	CcSEcCtD
Atomoxetine—Nausea—Betamethasone—systemic lupus erythematosus	0.000166	0.00044	CcSEcCtD
Atomoxetine—Nausea—Dexamethasone—systemic lupus erythematosus	0.000166	0.00044	CcSEcCtD
Atomoxetine—Urticaria—Methotrexate—systemic lupus erythematosus	0.000162	0.000428	CcSEcCtD
Atomoxetine—Dizziness—Prednisone—systemic lupus erythematosus	0.000161	0.000426	CcSEcCtD
Atomoxetine—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000161	0.000426	CcSEcCtD
Atomoxetine—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000161	0.000426	CcSEcCtD
Atomoxetine—Vomiting—Prednisone—systemic lupus erythematosus	0.000155	0.00041	CcSEcCtD
Atomoxetine—Rash—Prednisone—systemic lupus erythematosus	0.000154	0.000406	CcSEcCtD
Atomoxetine—Dermatitis—Prednisone—systemic lupus erythematosus	0.000154	0.000406	CcSEcCtD
Atomoxetine—Headache—Prednisone—systemic lupus erythematosus	0.000153	0.000404	CcSEcCtD
Atomoxetine—Asthenia—Methotrexate—systemic lupus erythematosus	0.000146	0.000386	CcSEcCtD
Atomoxetine—Nausea—Prednisone—systemic lupus erythematosus	0.000145	0.000383	CcSEcCtD
Atomoxetine—Pruritus—Methotrexate—systemic lupus erythematosus	0.000144	0.000381	CcSEcCtD
Atomoxetine—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.00014	0.000369	CcSEcCtD
Atomoxetine—Dizziness—Methotrexate—systemic lupus erythematosus	0.000135	0.000356	CcSEcCtD
Atomoxetine—Vomiting—Methotrexate—systemic lupus erythematosus	0.00013	0.000342	CcSEcCtD
Atomoxetine—Rash—Methotrexate—systemic lupus erythematosus	0.000129	0.00034	CcSEcCtD
Atomoxetine—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000128	0.000339	CcSEcCtD
Atomoxetine—Headache—Methotrexate—systemic lupus erythematosus	0.000128	0.000337	CcSEcCtD
Atomoxetine—Nausea—Methotrexate—systemic lupus erythematosus	0.000121	0.00032	CcSEcCtD
Atomoxetine—HTR6—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.19e-05	0.000841	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CCL2—systemic lupus erythematosus	1.18e-05	0.000838	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.18e-05	0.000834	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—NOS3—systemic lupus erythematosus	1.18e-05	0.000833	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.17e-05	0.000829	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NCF2—systemic lupus erythematosus	1.16e-05	0.000823	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.16e-05	0.000822	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—C3—systemic lupus erythematosus	1.16e-05	0.000822	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.16e-05	0.00082	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—LYN—systemic lupus erythematosus	1.15e-05	0.000818	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.15e-05	0.000817	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NCF2—systemic lupus erythematosus	1.15e-05	0.000817	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—F2—systemic lupus erythematosus	1.15e-05	0.000816	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—C3—systemic lupus erythematosus	1.15e-05	0.000815	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—LYN—systemic lupus erythematosus	1.15e-05	0.000811	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.14e-05	0.000806	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.14e-05	0.000805	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.13e-05	0.000802	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NCF2—systemic lupus erythematosus	1.13e-05	0.0008	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.13e-05	0.0008	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—C3—systemic lupus erythematosus	1.13e-05	0.000798	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.12e-05	0.000796	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—LYN—systemic lupus erythematosus	1.12e-05	0.000795	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	1.11e-05	0.000784	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.11e-05	0.000783	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.1e-05	0.000779	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.08e-05	0.000765	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.08e-05	0.000763	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.07e-05	0.000758	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.06e-05	0.000752	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.06e-05	0.00075	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.05e-05	0.000747	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—C3—systemic lupus erythematosus	1.05e-05	0.000746	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TLR9—systemic lupus erythematosus	1.05e-05	0.000744	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.05e-05	0.000742	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.05e-05	0.000741	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—C3—systemic lupus erythematosus	1.05e-05	0.00074	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	1.03e-05	0.000732	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.03e-05	0.000731	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CCL2—systemic lupus erythematosus	1.03e-05	0.000728	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—C3—systemic lupus erythematosus	1.02e-05	0.000725	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.02e-05	0.000722	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—F2—systemic lupus erythematosus	1.02e-05	0.000721	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.02e-05	0.00072	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—F2—systemic lupus erythematosus	1.01e-05	0.000716	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.01e-05	0.000712	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL2—systemic lupus erythematosus	9.98e-06	0.000706	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—IL6—systemic lupus erythematosus	9.93e-06	0.000703	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—F2—systemic lupus erythematosus	9.9e-06	0.000701	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	9.6e-06	0.00068	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—MMP9—systemic lupus erythematosus	9.44e-06	0.000669	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.41e-06	0.000666	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	9.38e-06	0.000664	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.38e-06	0.000664	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CSK—systemic lupus erythematosus	9.36e-06	0.000663	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	9.32e-06	0.00066	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.29e-06	0.000658	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—F2—systemic lupus erythematosus	9.25e-06	0.000655	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—JAK1—systemic lupus erythematosus	9.23e-06	0.000653	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.22e-06	0.000653	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—F2—systemic lupus erythematosus	9.18e-06	0.00065	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—JUNB—systemic lupus erythematosus	9.12e-06	0.000646	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TLR9—systemic lupus erythematosus	9.12e-06	0.000646	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—JUNB—systemic lupus erythematosus	9.05e-06	0.000641	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.03e-06	0.000639	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—F2—systemic lupus erythematosus	8.99e-06	0.000636	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—EP300—systemic lupus erythematosus	8.95e-06	0.000634	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—JUNB—systemic lupus erythematosus	8.86e-06	0.000628	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.85e-06	0.000627	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—P2RY12—systemic lupus erythematosus	8.83e-06	0.000625	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CCR5—systemic lupus erythematosus	8.74e-06	0.000619	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.67e-06	0.000614	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	8.62e-06	0.00061	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.6e-06	0.000609	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NCF2—systemic lupus erythematosus	8.56e-06	0.000606	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—C3—systemic lupus erythematosus	8.54e-06	0.000605	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—LYN—systemic lupus erythematosus	8.5e-06	0.000602	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.48e-06	0.0006	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.42e-06	0.000596	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PRL—systemic lupus erythematosus	8.4e-06	0.000595	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—JAK1—systemic lupus erythematosus	8.38e-06	0.000593	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SH2B3—systemic lupus erythematosus	8.34e-06	0.000591	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	8.34e-06	0.000591	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PRL—systemic lupus erythematosus	8.34e-06	0.000591	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.24e-06	0.000584	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.18e-06	0.000579	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PRL—systemic lupus erythematosus	8.17e-06	0.000578	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CSK—systemic lupus erythematosus	8.13e-06	0.000576	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	8.09e-06	0.000573	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	8.01e-06	0.000567	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.01e-06	0.000567	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCR5—systemic lupus erythematosus	7.94e-06	0.000562	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL2RA—systemic lupus erythematosus	7.83e-06	0.000554	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.78e-06	0.000551	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—C3—systemic lupus erythematosus	7.76e-06	0.000549	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	7.59e-06	0.000538	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—F2—systemic lupus erythematosus	7.5e-06	0.000531	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.49e-06	0.00053	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	7.48e-06	0.00053	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NCF2—systemic lupus erythematosus	7.43e-06	0.000526	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.43e-06	0.000526	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—C3—systemic lupus erythematosus	7.42e-06	0.000525	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LYN—systemic lupus erythematosus	7.38e-06	0.000523	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	7.28e-06	0.000515	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.27e-06	0.000515	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	7.24e-06	0.000513	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	7.03e-06	0.000498	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	6.89e-06	0.000488	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.86e-06	0.000486	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL12—systemic lupus erythematosus	6.84e-06	0.000485	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—F2—systemic lupus erythematosus	6.81e-06	0.000482	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.81e-06	0.000482	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	6.8e-06	0.000481	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—C3—systemic lupus erythematosus	6.74e-06	0.000477	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—JAK1—systemic lupus erythematosus	6.72e-06	0.000476	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—JUNB—systemic lupus erythematosus	6.72e-06	0.000476	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—JAK1—systemic lupus erythematosus	6.67e-06	0.000472	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.67e-06	0.000472	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—JAK1—systemic lupus erythematosus	6.53e-06	0.000462	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—F2—systemic lupus erythematosus	6.51e-06	0.000461	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	6.47e-06	0.000458	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6.38e-06	0.000452	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCR5—systemic lupus erythematosus	6.37e-06	0.000451	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCR5—systemic lupus erythematosus	6.32e-06	0.000448	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.28e-06	0.000444	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL2—systemic lupus erythematosus	6.23e-06	0.000441	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.23e-06	0.000441	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—C3—systemic lupus erythematosus	6.22e-06	0.000441	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PRL—systemic lupus erythematosus	6.19e-06	0.000438	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCR5—systemic lupus erythematosus	6.19e-06	0.000438	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL2—systemic lupus erythematosus	6.18e-06	0.000438	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—C3—systemic lupus erythematosus	6.18e-06	0.000437	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.1e-06	0.000432	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.07e-06	0.00043	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL2—systemic lupus erythematosus	6.05e-06	0.000429	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—C3—systemic lupus erythematosus	6.05e-06	0.000428	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.94e-06	0.000421	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—F2—systemic lupus erythematosus	5.92e-06	0.000419	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL6—systemic lupus erythematosus	5.86e-06	0.000415	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—JUNB—systemic lupus erythematosus	5.83e-06	0.000413	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.59e-06	0.000396	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	5.54e-06	0.000392	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—TYK2—systemic lupus erythematosus	5.51e-06	0.00039	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—F2—systemic lupus erythematosus	5.46e-06	0.000387	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—F2—systemic lupus erythematosus	5.42e-06	0.000384	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PRL—systemic lupus erythematosus	5.37e-06	0.000381	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—F2—systemic lupus erythematosus	5.31e-06	0.000376	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	5.27e-06	0.000373	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CD80—systemic lupus erythematosus	5.24e-06	0.000371	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CD80—systemic lupus erythematosus	5.2e-06	0.000368	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CD80—systemic lupus erythematosus	5.09e-06	0.00036	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.05e-06	0.000358	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.02e-06	0.000356	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—JAK1—systemic lupus erythematosus	4.95e-06	0.00035	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL2—systemic lupus erythematosus	4.87e-06	0.000345	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL2—systemic lupus erythematosus	4.83e-06	0.000342	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.79e-06	0.000339	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL2—systemic lupus erythematosus	4.73e-06	0.000335	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCR5—systemic lupus erythematosus	4.69e-06	0.000332	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.62e-06	0.000327	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL2—systemic lupus erythematosus	4.59e-06	0.000325	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—C3—systemic lupus erythematosus	4.58e-06	0.000325	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TYK2—systemic lupus erythematosus	4.42e-06	0.000313	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.39e-06	0.000311	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TYK2—systemic lupus erythematosus	4.39e-06	0.000311	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.39e-06	0.000311	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NOS3—systemic lupus erythematosus	4.34e-06	0.000307	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NOS3—systemic lupus erythematosus	4.31e-06	0.000305	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—JAK1—systemic lupus erythematosus	4.3e-06	0.000304	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TYK2—systemic lupus erythematosus	4.3e-06	0.000304	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	4.23e-06	0.000299	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NOS3—systemic lupus erythematosus	4.22e-06	0.000299	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCR5—systemic lupus erythematosus	4.07e-06	0.000288	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—F2—systemic lupus erythematosus	4.02e-06	0.000285	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.01e-06	0.000284	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL2—systemic lupus erythematosus	3.98e-06	0.000282	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—C3—systemic lupus erythematosus	3.98e-06	0.000282	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	3.94e-06	0.000279	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CD80—systemic lupus erythematosus	3.86e-06	0.000273	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.76e-06	0.000266	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.73e-06	0.000264	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL2—systemic lupus erythematosus	3.68e-06	0.000261	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6—systemic lupus erythematosus	3.66e-06	0.000259	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.65e-06	0.000259	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.65e-06	0.000259	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL2—systemic lupus erythematosus	3.65e-06	0.000259	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6—systemic lupus erythematosus	3.63e-06	0.000257	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	3.62e-06	0.000257	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL2—systemic lupus erythematosus	3.59e-06	0.000254	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL2—systemic lupus erythematosus	3.58e-06	0.000253	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6—systemic lupus erythematosus	3.56e-06	0.000252	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—F2—systemic lupus erythematosus	3.49e-06	0.000247	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MMP9—systemic lupus erythematosus	3.48e-06	0.000247	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.47e-06	0.000246	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MMP9—systemic lupus erythematosus	3.46e-06	0.000245	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.44e-06	0.000244	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MMP9—systemic lupus erythematosus	3.38e-06	0.00024	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.37e-06	0.000239	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	3.35e-06	0.000237	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—EP300—systemic lupus erythematosus	3.3e-06	0.000234	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—EP300—systemic lupus erythematosus	3.28e-06	0.000232	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	3.26e-06	0.000231	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—EP300—systemic lupus erythematosus	3.21e-06	0.000227	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	3.2e-06	0.000226	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.13e-06	0.000221	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	3.11e-06	0.000221	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.1e-06	0.00022	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.04e-06	0.000215	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.87e-06	0.000203	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.85e-06	0.000202	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.83e-06	0.0002	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.79e-06	0.000198	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.78e-06	0.000197	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.77e-06	0.000196	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	2.71e-06	0.000192	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	2.7e-06	0.000191	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	2.56e-06	0.000182	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.56e-06	0.000181	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	2.49e-06	0.000176	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	2.43e-06	0.000172	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.4e-06	0.00017	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	2.37e-06	0.000168	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	2.35e-06	0.000167	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.34e-06	0.000166	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.3e-06	0.000163	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	2.29e-06	0.000162	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	2.24e-06	0.000158	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.23e-06	0.000158	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.22e-06	0.000157	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6—systemic lupus erythematosus	2.16e-06	0.000153	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6—systemic lupus erythematosus	2.15e-06	0.000152	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	2.14e-06	0.000152	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.11e-06	0.00015	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	2.11e-06	0.00015	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6—systemic lupus erythematosus	2.1e-06	0.000149	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	2.06e-06	0.000146	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2e-06	0.000142	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.97e-06	0.000139	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	1.96e-06	0.000139	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.84e-06	0.00013	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.8e-06	0.000127	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	1.63e-06	0.000115	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	1.59e-06	0.000113	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.5e-06	0.000106	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.5e-06	0.000106	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	1.38e-06	9.79e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.35e-06	9.53e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.29e-06	9.11e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.18e-06	8.33e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	9.79e-07	6.93e-05	CbGpPWpGaD
